Life Science Leadership Series: Collaborating to Enable Precision Medicine


This event will look at drivers for precision medicine from discovery through to development of new therapies and how building collaborative relationship could be key for overcoming the barriers and driving innovation.

Dates Thursday, March 5, 2020 - Download as vCalendar
Event Times: 10:00 to 18:00
Venue The Royal Hospitals NHS Trust, St. Bartholomews Hospital West Smithfield London
Email info@onenucleus.com
Website Event website

Event details:

Along with advanced medicines, precision medicine is the next big thing.  Globally there is a big demand, and in the UK, it has been highlighted as an area of focus for the Industrial Strategy with an extra £210m of funding announced as part of the 2017 white paper.   Precision medicine aims to treat patients based upon their individual characteristics including genomics, environmental and lifestyle data.  It has the potential to have major impacts on patient outcomes and reduce the costs associated with ineffective treatments.  However, there are still challenges with this approach, including increasing complexity and volume of data available and reimbursement issues.

This event will look at drivers for precision medicine from discovery through to development of new therapies and how building collaborative relationship could be key for overcoming the barriers and driving innovation.

Programme:

10:00 Registration and Networking
10:30 Welcome
10:40 Keynotes and Scene Setting
12:00 Lunch
13:00  Drivers/Enablers for precision medicine – Early stage
14:30 Drivers/Enablers for precision medicine – Later stage
16:00 Panel – How can we collaborate to enable precision medicine?
16:45 Closing Remarks
16:50 Drinks and networking
18:00 Close

One Nucleus is a membership organisation for international life science and healthcare companies. We are based in Cambridge and London UK, the heart of Europe’s largest life science and healthcare cluster.